WPG Advisers
TGTX icon

WPG Advisers’s TG Therapeutics TGTX Stock Holding History

WPG Advisers’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$390 Buy
+7
New +$379 ﹤0.01% 1494

Other funds holding TGTX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

WPG Advisers's TGTX Position: Q3 2026 in Review

WPG Advisers opened a new position in TG Therapeutics (TGTX) in Q3 2026: 7 shares worth $390. The stake represents ﹤0.01% of the portfolio and ranks #1494 among its holdings.

361 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • WPG Advisers held 7 shares of TG Therapeutics worth $390 as of Q3 2026.
  • TG Therapeutics was a new WPG Advisers position in Q3 2026.
  • TG Therapeutics made up ﹤0.01% of WPG Advisers's portfolio in Q3 2026, its #1494 holding.
  • 361 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on WPG Advisers's 13F filing for Q3 2026, filed 27 Oct 2026.